Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 298

1.

ABCG8 polymorphisms and renal disease in type 2 diabetic patients.

Nicolas A, Fatima S, Lamri A, Bellili-Muñoz N, Halimi JM, Saulnier PJ, Hadjadj S, Velho G, Marre M, Roussel R, Fumeron F.

Metabolism. 2015 Jun;64(6):713-9. doi: 10.1016/j.metabol.2015.03.005. Epub 2015 Mar 14.

PMID:
25804128
2.

[Role of kidney injury molecule-1 (KIM-1) for inhospital event risk assessment after coronary artery bypass surgery].

Shafranskaia KS, Uchasova EG, Sumin DA, Krivoshapova KE, Kalaeva VV, Evseeva MV, Karetnikova VN, Barbarash OL, Barbarash LS.

Kardiologiia. 2014;54(9):4-10. Russian.

PMID:
25702396
3.

Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria.

Genctoy G, Arikan S, Gedik O.

Int Urol Nephrol. 2015 Feb;47(2):353-8. doi: 10.1007/s11255-014-0889-5. Epub 2014 Dec 24.

PMID:
25537827
4.

Anemia and estimated glomerular filtration rates.

Isakov E, Froom P, Henig C, Barak M.

Ann Clin Lab Sci. 2014 Fall;44(4):419-24.

PMID:
25361926
5.

Decreased retinol-binding protein 4 in the sera of patients with end-stage renal disease after kidney transplantation.

Zhang WX, Zhou W, Zhang ZM, Zhang ZQ, He JF, Shi BY.

Genet Mol Res. 2014 Oct 7;13(4):8126-34. doi: 10.4238/2014.October.7.7.

6.

Prognostic value of worsening renal function in outpatients with chronic heart failure.

Pimentel R, Couto M, Laszczyńska O, Friões F, Bettencourt P, Azevedo A.

Eur J Intern Med. 2014 Sep;25(7):662-8. doi: 10.1016/j.ejim.2014.06.002. Epub 2014 Jun 27.

PMID:
24986374
7.

Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria.

Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS.

Diabetes Care. 2014 Sep;37(9):2601-8. doi: 10.2337/dc13-1983. Epub 2014 Jun 4.

PMID:
24898299
8.

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.

Ng KP, Jain P, Heer G, Redman V, Chagoury OL, Dowswell G, Greenfield S, Freemantle N, Townend JN, Gill PS, McManus RJ, Ferro CJ.

Trials. 2014 May 6;15:158. doi: 10.1186/1745-6215-15-158.

9.

Pathogenesis of renal failure in multiple myeloma: any role of contrast media?

Mussap M, Merlini G.

Biomed Res Int. 2014;2014:167125. doi: 10.1155/2014/167125. Epub 2014 Apr 30. Review.

10.

The first clinical case of intermediate ex vivo normothermic perfusion in renal transplantation.

Hosgood SA, Nicholson ML.

Am J Transplant. 2014 Jul;14(7):1690-2. doi: 10.1111/ajt.12766. Epub 2014 May 9.

PMID:
24816186
11.

Renal vascular Doppler ultrasonographic indices and carotid artery intima-media thickness in diabetic nephropathy.

Ghadirpour A, Tarzamni MK, Naghavi-Behzad M, Abedi-Azar S, Koushavar H, Nezami N.

Med Ultrason. 2014 Jun;16(2):95-9.

12.

Predictive factors for adverse pregnancy outcomes after renal transplantation.

You JY, Kim MK, Choi SJ, Oh SY, Kim SJ, Kim JH, Oh HY, Roh CR.

Clin Transplant. 2014 Jun;28(6):699-706. doi: 10.1111/ctr.12367. Epub 2014 Apr 27.

PMID:
24654804
13.

Evaluation of renal function in patients with cirrhosis: where are we now?

Rognant N, Lemoine S.

World J Gastroenterol. 2014 Mar 14;20(10):2533-41. doi: 10.3748/wjg.v20.i10.2533. Review.

14.

Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.

Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ.

Can Assoc Radiol J. 2014 May;65(2):96-105. doi: 10.1016/j.carj.2012.11.002. Epub 2014 Feb 20.

PMID:
24559602
15.

Urine periostin as a biomarker of renal injury in chronic allograft nephropathy.

Satirapoj B, Witoon R, Ruangkanchanasetr P, Wantanasiri P, Charoenpitakchai M, Choovichian P.

Transplant Proc. 2014 Jan-Feb;46(1):135-40. doi: 10.1016/j.transproceed.2013.07.069.

PMID:
24507039
16.

Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure.

Wan ZH, Wang JJ, You SL, Liu HL, Zhu B, Zang H, Li C, Chen J, Xin SJ.

World J Gastroenterol. 2013 Dec 28;19(48):9432-8. doi: 10.3748/wjg.v19.i48.9432.

17.

Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.

Shariati-Sarabi Z, Ranjbar A, Monzavi SM, Esmaily H, Farzadnia M, Zeraati AA.

Int J Rheum Dis. 2013 Dec;16(6):731-8. doi: 10.1111/1756-185X.12059. Epub 2013 May 28.

PMID:
24382282
18.

End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease.

Bahirwani R, Forde KA, Mu Y, Lin F, Reese P, Goldberg D, Abt P, Reddy KR, Levine M.

Clin Transplant. 2014 Feb;28(2):205-10. doi: 10.1111/ctr.12298. Epub 2014 Jan 2.

19.

Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients.

Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H.

Clin Transplant. 2014 Jan;28(1):111-9. doi: 10.1111/ctr.12285. Epub 2013 Dec 24.

20.

C-terminal agrin fragment--a new fast biomarker for kidney function in renal transplant recipients.

Steubl D, Hettwer S, Vrijbloed W, Dahinden P, Wolf P, Luppa P, Wagner CA, Renders L, Heemann U, Roos M.

Am J Nephrol. 2013;38(6):501-8. doi: 10.1159/000356969. Epub 2013 Dec 14.

PMID:
24356308
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk